Prognostic significance of cell cycle proteins and genomic instability in borderline, early and advanced stage ovarian carcinomas

International Journal of Gynecological Cancer

Volumn 10, Issue 6, 2000, Pages 477-487

  Blegen, H ^a   Einhorn, N ^a   Sjovall K ^a   Roschke, A ^b   Ghadimi, B M ^b   Mcshane, L M ^b   Nilsson, B ^a   Shah, K ^c   Ried, T ^b   Auer, Gert ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NATIONAL CANCER INSTITUTE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Carcinoma; Cell cycle; Genomic instability; Ovary; Prognosis

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN A; CYCLIN E; DNA; KI 67 ANTIGEN; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ADENOCARCINOMA; ADVANCED CANCER; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE; CHROMOSOME 17P; CHROMOSOME ABERRATION; CHROMOSOME LOSS; EARLY CANCER; FEMALE; GENETIC STABILITY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PLOIDY; PRIORITY JOURNAL;

EID: 0034513784     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2000.00077.x     Document Type: Article

References (30)

1. Familial ovarian cancer: A population-based case-control study
2. Cancer statistics
3. FIGO annual report on the results of treatment in gynecological cancer
4. Discoveries in the cell cycle and ovarian cancer
5. Prognosis and management of borderline tumours of the ovary
6. Biological malignancy grading in early-stage ovarian carcinoma
7. Prognostic significance of DNA content and S-phase fraction in epithelial ovarian carcinomas analyzed by image cytometry
8. Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma
9. The combined evaluation of p53 Accumulation and of Ki-67 (MIB1) labelling index provides independent information on overall survival of ovarian carcinoma patients
10. P53 Accumulation in ovarian carcinomas and its prognostic implications
11. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
12. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breats cancer patients
13. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 In aggressive colorectal carcinomas
14. Low p27 Expression predicts poor disease-free survival in patients with prostate cancer
15. Expression of the cell cycle inhibitor p27KIP1 Is a new prognostic marker associated with survival in epithelial ovarian tumors
16. When checkpoints fail
17. Cell cycle checkpoints, chromosome stability and the progression of cancer
18. Abnormal centrosome amplification in the absence of p53
19. Karyotypic characteristics of borderline malignant tumors of the ovary: Trisomy 12, trisomy 7, and r(1) as nonrandom features
20. Simple numerical chromosome aberrations in well-differentiated malignant epithelial tumors
21. Chromosome aberrations in 35 primary ovarian carcinomas
22. Simple numeric abnormalities as primary karyotype changes in ovarian carcinoma
23. Genetic analysis of benign, low-grade, and high-grade ovarian tumors
24. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas
25. Simultaneous visualization of seven different DNA probes by in situ hybridization using combinatorial fluorescence and digital imaging microscopy
26. Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: A phenotype/genotype correlation
27. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein
28. Cyclin E, a redundant cyclin in breast cancer